Figure 1

Study schema. A total of 6152 AMI patients who were treated with moderate-to-high intensity atorvastatin and rosuvastatin were included in the final analysis. AMI acute myocardial infarction, KAMIR Korea Acute Myocardial Infarction Registry, PCI percutaneous coronary intervention; MACE major adverse cardiac events.